America’s Car-Mart Gets Additional $5 Million as Lenders Grant Temporary Waiver
Key Facts
Lenders to America’s Car-Mart approved additional term loans totaling $5 million for the company’s general purposes under an amendment executed on October 15, 2026. The company disclosed the financing in a filing with the U.S. Securities and Exchange Commission, noting that the additional loan is separate from the extension of the temporary waiver agreed later. The new loans mature on October 30, 2030, and are generally subject to the same interest rate and terms that apply to the initial loans, as amended. Separately, the agent and lenders agreed on October 20 to extend the waiver period through November 1, 2026. The financing gives the company additional liquidity, while the waiver of certain credit agreement requirements remains limited to a near-term date.
The temporary waiver covers minimum liquidity and collateral coverage ratio requirements, as well as anticipated or existing events of default, according to the company’s disclosure. The agreement did not extend these arrangements to the new loan’s 2030 maturity; the current extension ends on November 1, 2026. The company will pay the agent and lenders total fees of $200,000 for amending the credit agreement. The fees will be added to the outstanding principal balance under the agreement, according to the disclosure. This makes the amendment cost part of the company’s credit obligations, alongside the $5 million principal amount of the additional loans.
The amendment coincided with a change in collateral tied to the company’s financing. ACM Auto Trust 2024-2 redeemed all of its asset-backed notes on October 20, after which remaining receivables with aggregate principal of approximately $92 million were released. The company said those receivables were no longer pledged to secure the notes. Their release came as part of a broader financing arrangement that included the additional loan and the waiver extension, but it does not change the stated end date of the current waiver. The terms of the temporary waiver, including liquidity and collateral coverage requirements, remain tied to the extension through November 1.
The company’s results for the first quarter of its fiscal 2027 year show a steep decline in activity, with retail units down 81.9% and revenue down 57.3% from the comparable quarter. The chief executive said capital constraints had affected results for several quarters, and that the declines in units and revenue reflected financing and inventory constraints more than weak demand. The net charge-off rate as a percentage of average finance receivables also rose to 9.5%, from 6.6% in the comparable period. Accounts more than 30 days past due were 4.6%, compared with 4.1%. The company said net charge-offs increased by $24.4 million from the comparable quarter, attributing the increase to operational and economic factors, including the transition to centralized collections, fuel pressures and the cost of living.
The company’s stock, listed under the ticker CRMT, closed at $0.9464 on October 22, 2026, according to EL7 data. It closed at $1.04 on October 16 and $1.07 on October 19, before recording closes of $0.79 on October 20 and $0.6597 on October 21. The close then rose to $0.9464 on October 22. These prices show the daily closing path over that period, without identifying the reason for the moves or establishing that the stock reacted to the loan announcement. In a separate matter from the financing, the company said it continues to evaluate strategic alternatives under the oversight of a special committee of the board.
The alternatives cited by the company include financing, recapitalization, restructuring, mergers and acquisitions, as well as other transactions. The company did not specify an outcome of the review or a date for a decision in its disclosure. The near-term date stated in the credit arrangements remains November 1, 2026, when the current extension of the temporary waiver ends. The additional loans mature on October 30, 2030, under the terms of the amendment. The disclosure thus sets out the short-term financing path and strategic review alongside the extended loan obligations.